Life Technologies to Report Fourth Quarter and Fiscal Year 2012 on Feb. 4
CARLSBAD, Calif., Jan. 17, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it will report its fourth quarter and fiscal year 2012 financial results on Monday, Feb. 4 after market close.
Life Technologies' executives will conduct a webcast on the same day at 4:30 p.m. ET to discuss operating results, as well as future expectations.
The webcast can be accessed through the investor relations page of the Life Technologies website at ir.lifetechnologies.com/events.cfm. A replay of the webcast will be available on the Company's website through Monday, Feb. 25.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company with customers in more than 160 countries using its innovative solutions to solve some of today's most difficult scientific challenges. Quality and innovation are accessible to every lab with its reliable and easy-to-use solutions spanning the biological spectrum, with more than 50,000 products for agricultural biotechnology, translational research, molecular medicine and diagnostics, stem cell-based therapies, forensics, food safety and animal health. Its systems, reagents and consumables represent some of the most cited brands in scientific research including: Ion Torrent™, Applied Biosystems®, Invitrogen™, Gibco®, Ambion®, Molecular Probes® and Novex®. Life Technologies employs approximately 10,400 people and upholds its ongoing commitment to innovation with more than 4,000 patents and exclusive licenses. LIFE had sales of $3.7 billion in 2011. Visit us at our website: http://www.lifetechnologies.com.
SOURCE Life Technologies Corporation
More by this Source
Every Saudi's Choice to Have Genetic Code Mapped to Transform the Kingdom's Healthcare
Dec 08, 2013, 19:01 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.